Leap Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Leap Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Leap Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Leap Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $102 | 227 | 0.45 |
| 2025-03-31 | $69 | 227 | 0.30 |
| 2024-12-31 | $653 | 227 | 2.88 |
| 2024-09-30 | $583 | 227 | 2.57 |
| 2024-06-30 | $445 | 227 | 1.96 |
| 2024-03-31 | $604 | 227 | 2.66 |
| 2023-12-31 | $1.1k | 267 | 4.14 |
| 2023-09-30 | $338 | 242 | 1.40 |
| 2023-06-30 | $711 | 227 | 3.13 |